AgomAb Therapeutics NV

AgomAb Therapeutics NV

NNASDAQ:AGMB
5.92
USD
-0.05
(-0.84%)
639.24MMarket Cap
Mar 03Next Earn

AgomAb Therapeutics NV Documents

FY2025 · Annual report

Form 20-F · April 23, 2026 · 362 pages

Read AgomAb Therapeutics NV's results firsthand

Preview the first 2 pages of this annual report
Create a free account to start reading

Full documents are included with Professional

H2 2025 documents